Pain Killer, Anxiety and Mucogingival Therapy
Anxiety and Depression
About this trial
This is an interventional diagnostic trial for Anxiety and Depression
Eligibility Criteria
Inclusion Criteria: ASA type I and II subjects Localized Gingival Recessions Recessions Cairo RT I-II FMPS < 10% FMBS< 10% <10 cigs/ day No contra-indication against oral surgical interventions Patient is able to give inform consent Exclusion Criteria: Infection (local or systemic). Each infection will be evaluated prior to study procedure for suitability. Patients with gingivitis or local infection (fracture, apical reaction) will undergo a dental treatment prior to his entrance to the study. In case of systemic infection, the evaluation will be based on medical anamneses, and if necessary will be referred to relevant medical tests. ASA type > II Current pregnancy or breastfeeding women Alcoholism or chronically drug abuse Smokers, ≳ 10 cigarettes per day Immunocompromised patients Uncontrolled diabetes Untreated periodontitis History of previous periodontal surgery (mucogingival or other) on the teeth to be included Presence of severe tooth malposition, rotation or significant version of the tooth to be treated
Sites / Locations
- leila SalhiRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
Control group: free gingival graft for gingival recession
Test group: connective tissue graft for gingival recession